Since 2005, Philips Wellcentive has driven quality improvement, revenue growth and business transformation for healthcare organizations transitioning to value-based care. Our PHM solution provides long-term partnership services to impact clinical, financial and human outcomes. Recognized as a leader in population health management in reports by KLAS, IDC and Chilmark, Philips Wellcentive helps customers provide care management for more than 49 million patients and achieve more than $700 million in value-based reimbursements in 2016. Niki Buchanan, Business Leader, Philips Wellcentive
What emerging technologies hold the most potential for the healthcare industry?
Artificial Intelligence: Bringing its promise back to earth. HBR and others have reported on the importance of forgoing the moonshot of AI by identifying pragmatic applications of it. While health systems remain skeptical about the hype, deploying AI for business process improvements, supercharging analytics, and engaging patients has real promise. We’re deploying AI to predict risk in both home and care settings to drive better outcomes and lower costs. Actualizing Interoperability with brains, brawn and lessons learned. Today’s health systems find themselves wrapped in a “quilt” of solutions as they add a deluge of new technologies to their existing platforms. There is no single-vendor solution, and there is no substitute for insights, experience and doing the hard work to create accurate, actionable and truly interoperable data. While there are no shortcuts, the potential rewards are great, as the right population health management (PHM) solutions can provide comprehensive insights from outside the health system and across populations to drive true value-based care. Telehealth: More than a technology. Many see telehealth as a technology, but its genuine potential is found in its power to create a new access point and drive patient choice. Providers must be intentional about how and why they engage in virtual care. Telehealth is more than a substitute for how we’ve delivered care for hundreds of years. It is paving a path for a new care delivery model.
What are the challenges associated with strategically implementing innovative technologies?
Illuminating blind spots: Seeing beyond the EHR. Our analysis shows that even in markets with a “dominant” EHR, more than 40% of these delivery areas are strewn with many other vendors. When so much critical data exists outside the EHR, providers need visibility to a patients’ longitudinal care journey. EHRs will remain an important contributor, yet we need truly integrated data across the care continuum to keep populations healthy. Clinician time is under siege – optimized workflows are more important than ever. A primary care visit lasts just 18 minutes, but doctors must cover seven issues during that time. Given that some 50% of clinicians’ time is spent engaging with the EHR, less time is available to view the patient holistically. Getting longitudinal data in the workflow, at the point of care, is critical. We‘re partnering with other companies to provide that relief. Partnerships are perishable. As new technologies enter the market, so do a barrage of new vendors offering them—opening a floodgate of innovation. However, providers and vendors alike must carefully weigh new entrants and their ability to survive long-term to separate those with transformative merit from those that cannot stand the test of time. The cost of disruption caused by innovation that lacks enduring value is too high.
How can innovative technologies help healthcare organizations achieve the coveted triple aim?
Accelerating time to treatment. Telehealth plus predictive analytics improves access, builds workflows around patient needs and speeds their care. Partners Healthcare used the predictive capabilities of Philips CareSage and remote patient monitoring to reduce the risk of emergency transport in a frail elderly population, avoiding an estimated 224 hospital admissions and saving $2.2M. Hardwiring population health, now. Improving the health of populations can happen quickly. Ascension Medical Group at Borgess used our platform to identify, target and outreach to their diabetic population that had uncontrolled blood glucose levels. They set a lofty goal of reducing their hemoglobin A1c levels by 20% in one quarter. Our platform revealed that over 67% weren’t being seen in the office. Impressively, they exceeded their initial goal and have sustained improvements since the program began in 2015. They are a great example of having “hardwired” population health in their new care models.